The mi locus encodes a member of the basic ± helix ± loop ± helix ± leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF). Although the bHLH-Zip family transcription factors generally recognize and bind CANNTG motifs, the expression of mouse mast cell protease 6 (MMCP-6) gene is regulated by MITF through the GACCTG motif in the promoter region. The GACCTG motif was partly overlapped the TGTGGTC sequence, which was bound by polyomavirus enhancer binding protein 2 (PEBP2). In the present study, the eect of PEBP2 on the expression of MMCP-6 gene was examined. PEBP2 that is composed of a and b subunits was expressed by mast cell lines and cultured mast cells derived from spleen. The overexpression of dominant negative PEBP2 cDNA reduced the expression of MMCP-6. Moreover, the simultaneous transfection of the plasmid containing MITF cDNA and the plasmid containing PEBP2 cDNA increased the MMCP-6 promoter activity. For the synergistic action of PEBP2 and MITF, the intact GACCTG and TGTGGTC motifs were prerequisite. The PEBP2aB1 mutant which lacked the region downstream from the Runt domain did not bind MITF and lost the synergistic function. These results indicated that PEBP2 and MITF synergistically transactivated the MMCP-6 gene and that the region downstream from the Runt domain of PEBP2aB1 was essential for the physical and functional interactions with MITF.
Introduction
THE mi LOCUS of mice encodes a member of the basic ± helix ± loop ± helix ± leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called mi-transcription factor, MITF) (Hodgkinson et al., 1993; Hughes et al., 1993) . The MITF encoded by the mutant mi allele deletes 1 of 4 consecutive arginines in the basic domain (hereafter mi-MITF) (Hodgkinson et al., 1993; Hemesath et al., 1994; Steingrimsson et al., 1994) . The mi-MITF is defective in the DNA binding activity and the nuclear localization potential, and it does not transactivate target genes Takebayashi et al., 1996; Tsujimura et al., 1996; Jippo et al., 1997; Ito et al., 1998; Kim et al., 1998) . The mi/mi mice show microphthalmia, depletion of pigment in both hair and eyes, osteopetrosis, and decrease of mast cells (Silvers, 1979; Green, 1981; Stevens and Loutit, 1982; Stechschulte et al., 1987) . In addition to the decrease in number, the phenotype of mast cells is abnormal in mi/mi mice (Ebi et al., 1990 (Ebi et al., , 1992 Kasugai et al., 1993; Isozaki et al., 1994; Jippo et al., 1994) . We have demonstrated involvement of MITF in the transactivation of the mouse mast cell protease-6 (MMCP-6) , c-kit , MMCP-5 , p75 nerve growth factor receptor , Granzyme B, tryptophan hydroxylase , and integrin a4 subunit genes in mast cells .
We previously analysed the mechanism of the transactivation of the MMCP-6 gene by normal MITF (+-MITF) . The bHLH-Zip proteins including MITF recognize the CANNTG motif (any nucleotides are compatible with the position N) (Ephrussi et al., 1985) . Two CANNTG motifs, CACATG and CATCTG, are present in the MMCP-6 promoter, and are practically bound by +-MITF. The mutation of these motifs reduced the magnitude of transactivation by +-MITF, suggesting that the CACATG and CATCTG motifs directly mediated the transactivation by +-MITF. In addition to the CANNTG motifs, a GACCTG motif located upstream from the CANNTG motifs was also bound by +-MITF. The deletion or mutation of the GACCTG motif signi®cantly reduced the transactivation, and unexpectedly the magnitude of the reduction was greater after the mutation of the GACCTG motif than after the mutation of the CANNTG motifs . This suggested that the GACCTG motif played an important role for the transactivation by the +-MITF.
Most transcription factors cannot eectively work alone, but rather function in cooperation with other factors (Cross and Enver, 1997). In our previous experiments, we cotransfected the +-MITF and reporter plasmids into NIH3T3 cells to examine the transactivation of the MMCP-6 gene. There is a possibility that some endogenous factors in NIH3T3 cells might cooperate with the +-MITF to transactivate the MMCP-6 promoter through the GACCTG motif. We recognized that the GACCTG motif was overlapped by the TGTGGTC sequence (the overlapped nucleotides were underlined), which was bound by another transcription factor, polyomavirus enhancer binding protein 2 (PEBP2). PEBP2, also termed corebinding factor (CBF), is a heterodimer composed of a and b subunits, and three types of a subunits are known, aA, aB, and aC (reviewed by Ito and Bae, 1997) . Of the three, PEBP2aB corresponds to human AML1, which is the most frequent target of chromosomal translocation in human leukemia (Miyoshi et al, 1991; Look, 1997) , and essential for the development of de®nitive hematopoiesis (Okuda et al, 1996) . PEBP2aB has two alternatively spliced isoforms, aB1 and aB2. PEBP2 cooperates with other transcription factors, such as Ets-1 (Wotton et al., 1994; Sun et al., 1995 , Giese et al., 1995 , Kim et al., in press), Myb (Hernandez-Munain and Krangel, 1994 , and C/EBP (Zhang et al., 1994 (Zhang et al., , 1996 . In the present study, we examined whether PEBP2 worked synergistically with MITF. We found that only PEBP2aB1 cooperated with +-MITF among various PEBP2 proteins. The overexpression of dominant negative form of PEBP2aB1 reduced the expression of MMCP-6 gene in mast cells. PEBP2aB1 physically interacted and functionally cooperated with +-MITF.
Results

Expression of PEBP2aA, PEBP2aB or PEBP2aC gene in mast cells
We examined the expression of PEBP2aA, PEBP2aB or PEBP2aC gene by Northern blot analysis in IC-2 and MC/9 mast cell lines, P-815 and FMA/3 mastocytoma cell lines, and cultured mast cells (CMCs) derived from spleens of +/+ or mi/mi mice ( Figure 1 ). All mast cell lines, mastocytoma cell lines and CMCs expressed PEBP2aA mRNAs of 6.3 kb, 4.7 kb and 2.1 kb but not that of 7.4 kb. PEBP2aB mRNAs of 7.9 kb and 3.8 kb, which encode PEBP2aB2 and PEBP2aB1 respectively, were also detected in all mast cell lines, mastocytoma cell lines and CMCs. In contrast, PEBP2aC mRNA was hardly detectable.
Synergy of +-MITF with PEBP2aB1
Functional synergy was examined by the transient transfection of +-MITF and PEBP2. P19 cells were used as the target of transfection, since this system is ecient to demonstrate the transactivation ability of PEBP2 (Kanno et al., 1998; Kim et al., in press ). The plasmid containing +-MITF cDNA, the plasmid containing PEBP2aA, PEBP2aB1, PEBP2aB2 or PEBP2aC cDNA and the plasmid containing PEBP2b cDNA were used as eector plasmids. Since the PEBP2a normally function with PEBP2b in vivo (Kanno et al., 1998) , the plasmid containing PEBP2a cDNA and the plasmid containing PEBP2b cDNA were simultaneously transfected. The PEBP2a+ PEBP2b was called PEBP2a/b as the total. The luciferase gene under the control of MMCP-6 promoter starting from nucleotide (nt) 7171, which contained both the GACCTG and TGTGGTC motifs, was contransfected as the reporter with the eector plasmids ( Figure 2 ). The transfection of the plasmid containing PEBP2a/b cDNA did not increase the luciferase activity. The transfection of the plasmid containing +-MITF cDNA increased the luciferase activity sixfold. In contrast, the simultaneous transfection of the plasmid containing PEBP2aB1/b cDNA and the plasmid containing +-MITF cDNA increased the Figure 1 Expression of PEBP2aA, PEBP2aB or PEBP2aC mRNA in IC-2 and MC/9 mast cell lines, P-815 and FMA/3 mastocytoma cell lines and +/+ and mi/mi CMCs detected by Northern blotting. F9 cells, which do not express PEBP2aA, PEBP2aB and PEBP2aC mRNAs, were used as a negative control. NIH3T3 cells, which express PEBP2aA and PEBP2aB mRNAs, were used as a positive control in the expression of PEBP2aA and PEBP2aB genes. Subsequent hybridization with GAPDH probe served as a qualitative internal control Figure 2 Synergy between +-MITF and PEBP2 containing PEBP2aA, PEBP2aB1, PEBP2aB2 or PEBP2aC as the a subunit. The reporter plasmid contained the MMCP-6 promoter starting from nt7171. The eector plasmid contained +-MITF cDNA or PEBP2 (PEBP2a+PEBP2b) cDNA. The reporter plasmid and the eector plasmid were cotransfected into P19 cells, and the luciferase activity was measured. The eector plasmids were used in various combination as indicated in the ®gure. The data represent the mean+standard error (s.e.) of three experiments. In some cases, the s.e. was too small to be shown by the bars luciferase activity 30-fold (Figure 2 ). On the other hand, the simultaneous transfection of both the plasmid containing PEBP2aA/b cDNA and the plasmid containing +-MITF cDNA did not increase the luciferase activity obtained by the plasmid containing +-MITF cDNA alone. The simultaneous transfection of PEBP2aB2/b or PEBP2aC/b cDNA with +-MITF cDNA did not increase the luciferase activity obtained by the plasmid containing +-MITF cDNA alone, either.
Dominant negative mutant of PEBP2aB1
The dominant negative mutant of PEBP2aB1 was used to examine whether endogenous PEBP2aB1 is actually contributing to the promoter activity of the MMCP-6 gene. We used the dominant negative PEBP2aB1, which contained the Runt DNA binding domain but lacked the transactivation domain (Sakakura et al., 1994) . Since the Runt domain among PEBP2aA, PEBP2aB1 and PEBP2aC is almost identical, the overexpression of the dominant negative mutant would reduce the activity of PEBP2aA and PEBP2aC besides PEBP2aB1. As indicated in Figure 2 , however, PEBP2aA did not translativate the MMCP-6 promoter, and PEBP2aC was not expressed in mast cells. This was why the dominant negative mutant was used to examine the eect of endogenous PEBP2aB1. Overexpression of the dominant negative PEBP2aB1 reduced the level of MMCP-6 expression in MC/9 cells ( Figure 3 ). The amount of MMCP-6 mRNA was not aected by the transfection of the expression vector alone. In contrast to the expression of MMCP-6 gene, the expression of MMCP-5 and MC-CPA genes was not aected by the overexpression of dominant negative PEBP2aB1 (Figure 3 ). The expression level of +-MITF was not in¯uenced, either (data not shown).
Requirement of intact MITF and PEBP2 binding motifs for the functional synergy
The synergy between +-MITF and PEBP2aB1/b was observed when the reporter contained intact GACCTG and TGTGGTC motifs. No synergy was observed in the reporter mutated either at the GACCTG or the TGTGGTC motif, or mutated at both motifs (Figure 4a ). When the mi-MITF was used as an eector instead of +-MITF, the synergy was not observed either even if the reporter Figure 3 Eect of overexpression of the dominant negative PEBP2aB1 mutant on the expression of MMCP-6 gene. Expression of MMCP-6 mRNA was detected in MC/9 cells overexpressing either PEBP2aB1 mutant or the expression vector alone. Subsequent hybridization with MMCP-5, MC-CPA or GAPDH probe was carried out Figure 4 (a) Synergy between +-MITF and PEBP2aB1 detected by luciferse assay. The reporter plasmid contained the MMCP-6 promoter starting from nt7171. The eector plasmid contained +-MITF cDNA, mi-MITF cDNA, or PEBP2 (PEBP2aB1+ PEBP2b) cDNA. The reporter plasmid and the eector plasmid were cotransfected into P19 cells. The eector plasmids were used in various combination as indicated in the ®gure. The reporter plasmid mutated at either GACCTG or TGTGGTC motif, or mutated at both motifs was also used. (b) Synergy between +-MITF and PEBP2 in the reporter plasmid which had four copies of the fragment containing both the GACCTG and TGTGGTC motifs. The tetrameric fragments were cloned into a plasmid carrying the minimal MMCP-6 promoterstarting from nt761. The tetrameric fragments mutated at either GACCTG or TGTGGTC motif, or mutated at both motifs were also used. The data represent the mean+standard error (s.e.) of three experiments. In some cases, the s.e. was too small to be shown by the bars contained intact GACCTG and TGTGGTC motifs ( Figure 4a ). We next constructed the reporter plasmid which had four copies of the fragment containing both the GACCTG and TGTGGTC motifs. The tetrameric fragments were cloned into the plasmid carrying the minimal MMCP-6 promoter starting from nt 761. A signi®cant synergy between +-MITF and PEBP2aB1/b was observed in the reporter plasmid containing the tetrameric fragments but not in the reporter plasmid just containing the minimal MMCP-6 promoter ( Figure  4b ). No synergy was observed in the reporter plasmid which contained the tetrameric fragments mutated either at the GACCTG or TGTGGTC motif, or mutated at both motifs (Figure 4b ).
Interaction between +-MITF and PEBP2aB1
The co-immunoprecipitation studies were performed to con®rm the interaction betwen +-MITF and PEBP2aB1. COS-7 cells were transfected with expression plasmids containing a Myc-tagged +-MITF or a FLAG-tagged PEBP2aB1 cDNA, and their nuclear extracts were subjected to immunoprecipitation. After the immunoprecipitation of PEBP2aB1 complexes with an anti-FLAG antibody, the co-precipitated +-MITF Figure 5 Co-immunoprecipitation of PEBP2aB1 and +-MITF. COS-7 cells were transfected with the expression plasmids for Myc-tagged-+-MITF and FLAG-tagged-PEBP2aB1, and their nuclear extracts were used 
Region required for the synergy
To identify the region required for the physical interaction with +-MITF, we carried out in vitro binding experiments by using various deletion mutants of PEBP2aB1 (Figure 6a ). The 35 S-labeled PEBP2aB1 was subjected to coprecipitation with GST or GST-+-MITF which was immobilized on glutathione-agarose beads, and the protein complex was analysed by SDS ± PAGE. The full-length PEBP2aB1(1 ± 451) bound GST-+-MITF-coated beads but not GST-coated beads. Among the progressive C-terminally deleted mutants, only PEBP2aB1(1 ± 177), which completely lacked the downstream region of Runt DNA binding domain, did not bind to GST-+-MITF-coated beads (Figure 6b ). Progressive N-terminal deletion revealed a signi®cant reduction in binding when the region between amino acid (aa) 240 and 290 was deleted (Figure 6c ). The interaction was completely abolished when the region between aa 290 and 349 was further deleted. The natural deleted variants, PEBP2aB2 and PEBP2aC, were also examined ( Figure 6d ). PEBP2aB2, which has the internal deletion between aa 178 and 243, bound +-MITF. PEBP2aC, which lacks an exon equivalent to exon 5 of PEBP2aB1, also bound +-MITF. We concluded that the wide region downstream from the Runt domain was involved in the interaction with +-MITF. Two subregions mostly contributed to this interaction. The C-terminal boundary of one subregion was aa 177 ± 183, and the N-terminal boundary of another subregion was aa 240 ± 290.
Variously deleted PEBP2aB1 (Figure 7a ) and PEBP2b were overexpressed with +-MITF to identify the region required for the functional synergy. The synergy was detected in the C-terminally deleted PEBP2aB1(1 ± 371), PEBP2aB1(1 ± 331) or PEBP2aB1 (1 ± 291), whereas the synergy between PEBP2aB1(1 ± 243) and +-MITF was hardly detectable (Figure 7b ).
Discussion
Two CANNTG motifs and a GACCTG motif are present in the 5'-promoter region of the MMCP-6 gene. Among them, the GACCTG motif shows the greatest transactivation potential . We investigated this reason in the present study and noticed that GACCTG motif is overlapped with the TGTGGTC motif, which is recognised and bound by transcription factors of PEBP2 family (reviewed by Ito and Bae, 1997) . Although mast cell lines, mastocytoma cell lines and CMCs expressed PEBP2aA, PEBP2aB1 and PEBP2aB2 mRNAs, only the overexpression of PEBP2aB1 enhanced the transactivation of MMCP-6 promoter. In order to examine the function of PEBP2aB1 protein in mast cells, a dominant negative mutant of PEBP2aB1 was overexpressed in the MC/9 mast cell line which expressed both PEBP2aB1 and MITF genes. The expression of the MMCP-6 mRNA was signi®cantly suppressed. Since the overexpression of dominant negative PEBP2aB1 did not suppress the expression of MMCP-5 and MC-CPA mRNAs, the suppression of MMCP-6 mRNA by dominant negative PEBP2aB1 appeares to be speci®c.
CMCs of mi/mi genotype do not express the MMCP-6 gene in spite of the fact that mi/mi CMCs normally express PEBP2aB1. Therefore, simultaneous expression of both PEBP2aB1 and +-MITF appeares necessary for the normal expression of the MMCP-6 gene. In fact, co-expression of PEBP2aB1 and +-MITF cDNAs in P19 cells signi®cantly enhanced the expression of the luciferase gene under the control of MMCP-6 promoter.
We examined whether the overlapping GACCTGTGGTC motif are really necessary for the transactivation by both MITF and PEBP2aB1. The reporter plasmid containing the tetrameric GACCTGTGGTC motifs and the minimal MMCP-6 promoter may function as the target of both MITF and PEBP2aB1 transcription factors.
Cooperation of transcription factors which bound in the neighboring region of the promoter have been reported. PEBP2 and c-Myb synergistically transactivate the T cell receptor d promoter through the neighboring TGTGGTTT and CCGTTA motifs Krangel, 1994, 1995) . PEBP2 and Ets also synergistically transactivate T cell receptor a promoter (Wotton et al., 1994; Sun et al., 1995; Giese et al., 1995; Kim et al., in press ). In the case of the synergy between PEBP2 and Ets, the binding motif of Ets is partly overlapped on the binding motif of PEBP2 (CAGGAT and TGTGGTT, respectively) as observed in the MMCP-6 promoter. The cooperation of PEBP2 with c-Myb or Ets requires the intact binding motifs. This suggests that both proteins simultaneously bind the closely located motifs to function synergistically (Hernandez-Munain and In some cases, the s.e. was too small to be shown by the bars Krangel, 1994 Krangel, , 1995 Wotton et al., 1994) . In the present study, the intact GACCTG and TGTGGTC motifs were necessary for the synergistic function between MITF and PEBP2. The mutation at the GACCTG motif to TCCCTG and the mutation at the TGTGGTC motif to TGTTATC abolished the synergy. The mutation at the GACCTG motif abolished the binding of +-MITF, and the mutation at the TGTGGTC motif abolished the binding of PEBP2aB1 (data not shown). This suggested that the binding of +-MITF to GACCTG and that of PEBP2 to TGTGGTC appeared to be necessary for the functional interaction.
The region of PEBP2aB1 (aa 177 ± 349) downstream from the Runt domain was required for both the in vitro binding with MITF and the functional synergy. In this relatively wide region, two subregions turned out to be particularly important. This is consistent with the result that PEBP2aB2, which lacks the region between aa 178 and 242, did not show a synergy with MITF. Also, a signi®cant reduction in binding observed when the region aa 240 ± 290 was deleted correlated well with the loss of functional synergy with the construct aB1(1 ± 243). In a previous work, the region between aa 243 and 291 was de®ned as the transactivation element (TE) 3 than the other two TEs in PEBP2aB1, TE1 and TE2. In the present study, it is shown that TE3 is important for the synergistic transactivation with MITF, and this same element is also important for the functional synergy with C/EBPa (Kanno et al., unpublished observation) .
Taken together, PEBP2 transactivated the MMCP-6 gene in cooperation with +-MITF. The region downstream from the Runt DNA binding domain of PEBP2aB1 is essential for the physical and functional interactions between PEBP2 and +-MITF.
Materials and methods
Mice and cells
The original stock of C57BL/6-mi/+ (mi/+) mice was purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and were maintained in our laboratory by consecutive backcrosses to our own inbred C57BL/6 colony (more than 15 generations at the time of the present experiment). Female and male mi/+ mice were crossed together, and the resulting mi/mi mice were selected by their white coat color (Silvers, 1979; Green, 1981) . Pokeweed mitogen-stimulated spleen cell conditioned medium (PWM-SCM) was prepared according to the method described by Nakahata and Ogawa (1982) . Mice of mi/mi and control C57BL/6-+/+ (+/+) mice were used at 2 ± 3 weeks of age to obtain CMCs. Mice were killed by decapitation after ether anesthesia and spleens were removed. Spleen cells derived from mi/mi or +/+ mice were cultured in a-minimal essential medium (a-MEM; ICN Biomedicals, Costa Mesa, CA, USA) supplemented with 10% PWM-SCM and 10% fetal calf serum (FCS; Nippon Biosupp Center, Tokyo, Japan). Half of the medium was replaced every 3 days. The mast cell lines, IC-2 and MC/9 were also maintained in a-MEM supplemented with 10% PWM-SCM and 10% FCS. Mouse mastocytoma cell lines, P-815 and FMA/3 were maintained in a-MEM supplemented with 10% FCS. P19 cell was maintained in a cocktail of DMEM and HAM-F12 (1 : 1) supplemented with 10% FCS. NIH3T3 ®broblast cell line and COS-7 cells were maintained in DMEM supplemented with 10% FCS.
Northern blot analysis
Total RNAs were prepared using the lithium chlorideurea method (Auray and Rougenon, 1980) . Total RNA from F9 cells was kindly provided by Dr Y Nishimune (Osaka University, Osaka, Japan). The fragments of PEBP2aA, PEBP2aB, PEBP2aC, MMCP-5, MMCP-6, MC-CPA and GAPDH cDNAs were used as probes after being labeled with 32 P-a-dCTP (DuPont/NEN Research Products, Boston, MA, USA; 10 mCi/mL) by random oligonicleotide priming (Bae et al., 1993; Reynolds et al., 1989 Reynolds et al., , 1991 Sabath et al., 1990; Satake et al, 1995) . After hybridization at 428C, blots were washed to a ®nal stringency of 0.26SSC (16SSC is 150 mmol/L NaCl, 15 mmol/L trisodium citrate, pH 7.4) at 508C and subjected to autoradiography.
Construction of expression and reporter plasmids
Bluescript KS (7) plasmid (pBS; Stratagene, La Jolla, CA, USA) containing the whole coding region of +-MITF or mi-MITF had been constructed in our laboratory (hereafter called pBS-+-MITF and pBS-mi-MITF, respectively) . pEF-BOS expression vector was kindly provided by Dr S Nagata (Osaka University Medical School, Osaka, Japan) (Mizushima and Nagata, 1990) . The SmaI ± HincII fragment of pBS-+-MITF or pBS-mi-MITF was introduced into the blunted XbaI site of pEF-BOS (hereafter called BOS-+-MITF and BOS-mi-MITF, respectively). The expression plasmids containing various deleted PEBP2aB1 constructs were reported elsewhere (Kanno et al., 1998) . The FLAGtagged PEBP2aB1 expression plasmid was constructed by inserting the tagging sequence and coding sequence into pCDNA3.1 (In Vitrogen, San Diego, CA, USA). The Myctagged +-MITF construct was described before . The reporter plasmid which contained the MMCP-6 promoter starting from nt 7171 was described previously . The reporter plasmids mutated either at the GACCTG or the TGTGGTC motif, or mutated at both motifs were constructed by PCR. The GACCTG motif was mutated to TCCCTG. The TGTGGTC motif was mutated to TGTTATC. The mutation at GACCTG motif abolished the binding of +-MITF, and the mutation at the TGTGGTC motif abolished the binding of PEBP2aB1 (data not shown). The reporter plasmid which contained minimal MMCP-6 promoter starting from nt 761 was also constructed by PCR. The fragment between nt 7171 and 7151 of the MMCP-6 promoter was multimerized, and ligated into the upstream from the minimal MMCP-6 promoter. All of the deleted or mutated products were veri®ed by sequencing.
Transfection of reporter plasmids and luciferase assay
Reporter (9 mg) and eector plasmids were cotransfected into P19 cells by calcium phosphate method. The plasmid containing +-or mi-MITF cDNA (2 mg), containing PEBP2a cDNA (0.3 mg), or containing PEBP2b cDNA (0.1 mg) was used as eector plasmid. The cells were harvested 24 h after the transfection and lysed with 0.1 mol/L potassium phosphate buer (pH 7.4) containing 1% Triton X-100. Soluble extracts were then assayed for luciferase activity with a luminometer LB96P (Berthold GmbH, Wildbad, Germany). The luciferase activity was normalized by the protein content.
x
Overexpression of dominant negative PEBP2aB1 mutant
The expression plasmid containing the dominant negative PEBP2aB1 mutant was previously reported (Sakakura et al., 1994) . Shortly, the BstEI-Sau3A1 fragment (nt 395 ± 807 of PEBP2aB1 cDNA) that contained the Runt domain of PEBP2aB1 was ligated with XhoI linlers at both ends, and inserted into the XhoI site of pCX2neo vector. MC/9 cells (1610 7 ) were mixed with 10 mg of the linearized expression plasmid, and electroporated at 300 V/975 mF with a Gene Pulser (Bio-Rad Laboratories, Hercules, CA, USA). The G-418 resistant cells were isolated after 4 weeks, and the expression of exogenous PEBP2aB1 was examined by RT ± PCR with the following primers: sense primer, 5'-GCAACGTGCTGGTTGTTG corresponding to the sequence in the globin gene in pCX2neo, antisense primer, 5'-CGATGTCTTCGGGGTTCT corresponding to the Runt domain of PEBP2aB1 (nt 776 ± 793).
Immunoprecipitation
The COS-7 cells were transfected with 10 mg each of the expression plasmids. Forty-eight hours after transfection, the nuclear extracts were prepared as described previously . The nuclear extract was incubated with 350 ml of LIP buer (10 mM HEPES, 250 mM NaCl, 0.1% Nonidet P-40, 5 mM EDTA, 1 mM PMSF) and Protein G-Sepharose (Amersham-Pharmacia Biotec, Bucks, UK) for 1 h with gentle rocking and centrifuged at 15 000 r.p.m. for 1 min. The supernatant was transferred into a new tube and incubated with the monoclonal antibody directed to the FLAG tag (Sigma, St Louis, MA, USA) or to the Myc tag (9E10, Pharmingen, San Diego, CA, USA) and protein G-Sepharose for 2 h on ice in LIP buer. The immune complex was washed four times with LIP buer. Samples were resuspended in loading buer, analysed by SDS ± PAGE, and immunoblotted with anti-Myc tag antibody.
Puri®cation of recombinant proteins and in vitro binding assays
The +-MITF protein was expressed in Escherichia coli as a GST fusion protein, and immobilized on glutathione-agarose beads according to the manufacturer's instructions (Pharmacia Biotech, Uppsala, Sweden). The 35 S-methioninelabeled, in vitro-translated PEBP2aproteins were prepared with the TNT system (Promega, Madison, WI, USA). GST or GST-+-MITF (2 mg) immorbilized on glutathione-agarose beads was incubated with in vitro-translated 35 S-labeled PEBP2a for 1 h at room temperature with gentle rotation. The beads were washed four times and subjected to SDS ± PAGE on a 10% acrylamide gel.
